Down-regulation of the let-7i facilitates gastric cancer invasion and metastasis by targeting COL1A1

References

[1] Acunzo M, Croce CM (2016) Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia. Clin Chem 62:655–656

[2] Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7:1–9

[3] Boguslawska J, Kedzierska H, Poplawski P, Rybicka B, Tanski Z, Piekielko-Witkowska A (2015) Expression of genes involved in cellular adhesion and extracellular matrix remodeling correlates with poor survival of patients with renal cancer. J Urol 195:1892–1902

[4] Chai F, Liang Y, Zhang F, Wang M, Zhong L, Jiang J (2016) Systematically identify key genes in inflammatory and noninflammatory breast cancer. Gene 575:600–614

[5] Croce CM, Calin GA (2005) miRNAs, cancer, and stem cell division. Cell 122:6–7

[6] Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, Terashima M, Kawashima Y,Fukunaga T, Gotoh M (2016) Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer 20:332–340

[7] Grigoroiu M, Tagett R, Draghici S, Dima S, Nastase A, Florea R, Sorop A, Ilie V, Bacalbasa N, Tica V (2015) Gene-expression profiling in non-small cell lung cancer with invasion of mediastinal lymph nodes for prognosis evaluation. Cancer Genomics Proteomics 12:231–242

[8] Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070

[9] Liu K, Qian T, Tang L, Wang J, Yang H, Ren J (2012) Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer. World J Surg Oncol 10:225

[10] Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223

[11] Ozkan K, Turkkan E, Ender K, Mutlu D, Murat A, Nalan B, Abdulmecit Y, Osman M (2005) 5-Fluorouracil, epirubicin and cisplatin in the treatment of metastatic gastric carcinoma: a retrospective analysis of 68 patients. Indian J Cancer 42:85–88

[12] Shi Y, Wang J, Xin Z, Duan Z, Wang G, Li F (2015) Transcription factors and microRNA-co-regulated genes in gastric cancer invasion in ex vivo. PLoS ONE 10:e0122882

[13] Wu W, Lin Z, Zhuang Z, Liang X (2009) Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 18:50–55

[14] Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L (2008) MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 68:10307–10314

[15] Yang WH, Lan HY, Tai SK, Yang MH (2013) Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells. Biochem Biophys Res Commun 433:24–30

RIGHTS & PERMISSIONS

The Author(s) 2018